시장보고서
상품코드
1828935

항비만제 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 형태별, 최종 사용자별, 디바이스별, 모드별(-2034년)

Anti Obesity Drugs Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Form, End User, Device, Mode

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 331 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

항비만제 시장은 2024년 172억 달러에서 2034년 1,641억 달러로 확대될 전망이며, CAGR 약 25.3%로 성장할 것으로 예측됩니다. 항비만제 시장에는 식욕 감퇴, 대사 촉진, 지방 흡수 억제로 체중 감소를 지원하도록 설계된 의약품이 포함됩니다. 이 시장을 견인하는 것은 비만률 상승, 라이프 스타일 변화, 건강 의식 증가입니다. 혁신은 효과, 안전 및 최소한의 부작용에 중점을 두고 규제 당국의 승인이 시장 역학을 형성합니다. 전략적 파트너십 및 연구 투자는 세계적인 비만의 유행에 대처하는 데 매우 중요하며 큰 성장 기회를 제공합니다.

항비만제 시장은 비만률 상승 및 건강 위험에 대한 의식이 높아지면서 큰 성장을 이루고 있습니다. 약물 치료 분야는 체중 관리와 대사 개선에 효과적인 GLP-1 수용체 작용제가 주도하고 있습니다. 이에 약간의 차이가 계속되는 것은 시너지 효과와 환자의 결과 개선을 가져오는 병용약입니다. 처방약의 하위 부문은 의사의 권고와 입증된 임상 결과에 의해 시판약을 능가합니다. 장내 마이크로바이옴 조절제와 같은 새로운 치료법은 체중 감량에 대한 참신한 접근법으로 주목을 받고 있습니다. 소아용 항비만제 분야도 소아 비만의 우려에 대응함으로써 성장이 예상되고 있습니다. 경구제 및 주사제를 포함한 약물 전달 시스템의 혁신은 환자의 컴플라이언스를 높이고 시장의 호소력을 확대합니다. 맞춤형 의료는 유전자 프로파일링을 통해 맞춤형 치료 전략을 이끌어 가고 있으며 점점 더 관련성이 높아지고 있습니다. 제약업계의 지속적인 연구개발 노력과 전략적 파트너십에 힘입어 시장은 확대를 향하고 있습니다.

시장 세분화
유형별 처방약, 시판약, 허브 보충제
제품별 식욕 억제제, 대사 촉진제, 지방 흡수 억제제, 배합제
서비스별 상담 서비스, 체중 관리 프로그램, 라이프 스타일 상담
기술별 파마코유전체학, 나노기술, 생명공학
컴포넌트별 의약품 유효 성분, 부형제
용도별 만성 비만증, 체중 관리
투약 형태별 정제, 캡슐, 액체, 주사제
최종 사용자별 병원, 클리닉, 재택 케어 시설, 웰니스 센터
디바이스별 의료 기기, 웨어러블 기기
모드별 경구제, 주사제

시장 현황

항비만제 시장은 여러 기업이 혁신적인 제품을 도입하고 시장 점유율이 역동적으로 변화하고 있습니다. 효과적인 체중 관리 솔루션에 대한 수요를 반영하여 가격 전략은 여전히 경쟁적입니다. 신제품 출시는 첨단 제형 및 전달 메커니즘에 중점을 두고 소비자의 관심을 높이는 데 기여하고 있습니다. 시장은 개인화된 의료 동향을 목격하고 있으며, 각 회사는 맞춤형 솔루션을 제공하기 위해 연구개발에 투자하고 있습니다. 경쟁 벤치마킹은 전략적 제휴 및 인수를 활용하여 시장에서의 지위를 높이고 있는 주요 기업의 우위를 강조하고 있습니다. 규제의 영향은 크고 엄격한 지침이 의약품 승인 프로세스에 영향을 미치고 있습니다. 그러나 이러한 규제는 높은 안전성과 유효성의 기준도 확보하여 소비자의 신뢰를 양성하고 있습니다. 시장은 급속한 기술 진보를 특징으로 하며 AI와 데이터 분석이 의약품 개발에 중요한 역할을 하고 있습니다. 세계적으로 보면 북미와 유럽을 필두로 도입률은 다양하지만 신흥 시장은 미개발 성장의 가능성을 지니고 있습니다.

주요 동향 및 성장 촉진요인 :

항비만제 시장은 비만률의 상승 및 건강 위험에 대한 의식의 고조에 힘입어 강력한 성장을 이루고 있습니다. 치료제 개발의 기술적 진보로 부작용이 적고 효과적인 치료법이 개발되어 시장 확대의 원동력이 되고 있습니다. 라이프 스타일의 변화와 앉기 쉬운 생활 습관이 비만율의 상승에 기여하고 있어 의약품에 의한 개입이 필요해지고 있습니다. 체중 관리 및 비만 예방을 추진하는 정부의 이니셔티브와 헬스케어 정책은 시장을 더욱 촉진하고 있습니다. 맞춤형 의료 수요는 표적 요법의 기술 혁신을 촉진하고 약물의 효능과 환자 결과를 향상시킵니다. 게다가, 디지털 헬스툴의 통합은 환자의 어드히어런스와 모니터링을 지원하고 치료의 성공을 뒷받침하고 있습니다. 신흥 시장은 의료 인프라 성장과 가처분 소득 증가로 유리한 비즈니스 기회를 제공합니다. 제약 기업 간 전략적 제휴 및 공동연구는 연구개발을 촉진하고 신규 항비만제의 도입을 가속화하고 있습니다. 비만과 관련된 합병증에 대한 인식이 높아짐에 따라 시장은 환자 중심의 종합적인 해결책에 중점을 두고 지속적인 성장을 이루는 태세를 갖고 있습니다.

성장 억제요인 및 과제 :

항비만제 시장은 현재 몇 가지 중요한 시장 성장 억제요인 및 과제에 직면하고 있습니다. 주요 억제요인은 엄격한 승인 프로세스를 부과하고 신약 시장 도입을 지연시키는 엄격한 규제 환경입니다. 이러한 규제의 복잡성은 제약 회사들에게 종종 비용 증가 및 타임라인의 장기화로 이어집니다. 또 다른 과제는 의약품 개발과 상업화에 드는 높은 비용이며, 이는 투자와 기술 혁신을 저해하고 있습니다. 새로운 항비만 솔루션을 시장에 투입하려고 할 때 많은 기업들이 경제적 장벽에 직면하게 됩니다. 게다가 비만에 관련된 스티그마(낙인)는 뿌리 깊고 환자의 낮은 복약 준수 및 치료에 대한 소극성으로 이어져, 이것이 시장의 가능성을 손상시키고 있습니다. 게다가, 현재의 항비만제의 제한된 효능과 부작용이 시장의 장애가 되어 환자와 의사의 기대에 부응하지 않는 경우가 많습니다. 마지막으로, 제일선택 치료로서 생활습관 및 식사에 대한 개입이 중시되게 되어 있는 것이 약리학적 해결책에 대한 수요를 더욱 저하시켜 시장 성장에 영향을 주고 있습니다.

주요 기업

Orexigen Therapeutics, Vivus, Arena Pharmaceuticals, Zafgen, Rhythm Pharmaceuticals, Novo Nordisk, Gelesis, Eisai Co Ltd, Alyzyme Therapeutics, NeuroSearch, Sorrento Therapeutics, Amgen, Allergan, Saniona, 8i Ventures

목차

제1장 항비만제 시장 개요

  • 조사 목적
  • 항비만제 시장 정의 및 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 기간 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 항비만제 시장 전망

  • 항비만제 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 항비만제 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 항비만제 시장 규모

  • 항비만제 시장 규모 : 금액 기준
  • 항비만제 시장 규모 : 수량별

제7장 항비만제 시장 : 유형별

  • 시장 개요
  • 처방약
  • 시판약
  • 허브 보충제
  • 기타

제8장 항비만제 시장 : 제품별

  • 시장 개요
  • 식욕 억제제
  • 대사 촉진제
  • 지방 흡수 억제제
  • 배합제
  • 기타

제9장 항비만제 시장 : 서비스별

  • 시장 개요
  • 컨설테이션 서비스
  • 체중 관리 프로그램
  • 라이프스타일 상담
  • 기타

제10장 항비만제 시장 : 기술별

  • 시장 개요
  • 파마코유전체학
  • 나노기술
  • 생명공학
  • 기타

제11장 항비만제 시장 : 성분별

  • 시장 개요
  • 원약
  • 부형제
  • 기타

제12장 항비만제 시장 : 용도별

  • 시장 개요
  • 만성 비만
  • 체중 관리
  • 기타

제13장 항비만제 시장 : 형태별

  • 시장 개요
  • 태블릿
  • 캡슐제
  • 액체
  • 주사제
  • 기타

제14장 항비만제 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 진료소
  • 재택 치료
  • 웰니스 센터
  • 기타

제15장 항비만제 시장 : 디바이스별

  • 시장 개요
  • 의료기기
  • 웨어러블 디바이스
  • 기타

제16장 항비만제 시장 : 모드별

  • 시장 개요
  • 경구제
  • 주사제
  • 기타

제17장 항비만제 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제19장 기업 프로파일

  • Orexigen Therapeutics
  • Vivus
  • Arena Pharmaceuticals
  • Zafgen
  • Rhythm Pharmaceuticals
  • Novo Nordisk
  • Gelesis
  • Eisai Co Ltd
  • Alizyme Therapeutics
  • NeuroSearch
  • Sorrento Therapeutics
  • Amgen
  • Allergan
  • Saniona
  • 8i Ventures
AJY 25.10.15

Anti Obesity Drugs Market is anticipated to expand from $17.2 billion in 2024 to $164.1 billion by 2034, growing at a CAGR of approximately 25.3%. The Anti Obesity Drugs Market encompasses pharmaceuticals designed to aid weight loss by reducing appetite, increasing metabolism, or inhibiting fat absorption. This market is driven by rising obesity rates, lifestyle changes, and increasing health awareness. Innovations focus on efficacy, safety, and minimal side effects, with regulatory approvals shaping market dynamics. Strategic partnerships and research investments are pivotal in addressing the global obesity epidemic, offering significant growth opportunities.

The Anti-Obesity Drugs Market is experiencing significant growth, propelled by rising obesity rates and increased awareness of health risks. The pharmacotherapy segment dominates, with GLP-1 receptor agonists leading due to their efficacy in weight management and metabolic improvement. Following closely are combination drugs, which offer synergistic effects and enhanced patient outcomes. The prescription drugs sub-segment outperforms over-the-counter options, driven by physician recommendations and proven clinical results. Emerging therapies, such as gut microbiome modulators, are gaining attention for their novel approach to weight loss. The pediatric anti-obesity drugs segment is also expected to grow, addressing childhood obesity concerns. Innovations in drug delivery systems, including oral and injectable formulations, enhance patient compliance and broaden market appeal. Personalized medicine is becoming increasingly relevant, with genetic profiling guiding tailored therapeutic strategies. The market is poised for expansion, supported by ongoing research and development efforts and strategic partnerships in the pharmaceutical industry.

Market Segmentation
TypePrescription Drugs, Over-the-Counter Drugs, Herbal Supplements
ProductAppetite Suppressants, Metabolic Enhancers, Fat Absorption Inhibitors, Combination Drugs
ServicesConsultation Services, Weight Management Programs, Lifestyle Counseling
TechnologyPharmacogenomics, Nanotechnology, Biotechnology
ComponentActive Pharmaceutical Ingredients, Excipients
ApplicationChronic Obesity, Weight Management
FormTablets, Capsules, Liquid, Injectables
End UserHospitals, Clinics, Home Care Settings, Wellness Centers
DeviceMedical Devices, Wearable Devices
ModeOral, Injectable

Market Snapshot:

The Anti Obesity Drugs Market is experiencing a dynamic shift in market share, with several companies introducing innovative products. Pricing strategies remain competitive, reflecting the demand for effective weight management solutions. New product launches are focusing on advanced formulations and delivery mechanisms, contributing to heightened consumer interest. The market is witnessing a trend towards personalized medicine, with companies investing in research and development to offer tailored solutions. Competition benchmarking highlights the dominance of key players who are leveraging strategic partnerships and acquisitions to enhance their market position. Regulatory influences are significant, with stringent guidelines affecting drug approval processes. However, these regulations also ensure high safety and efficacy standards, fostering consumer trust. The market is characterized by rapid technological advancements, with AI and data analytics playing crucial roles in drug development. The global landscape shows varying adoption rates, with North America and Europe leading, while emerging markets present untapped potential for growth.

Geographical Overview:

The anti-obesity drugs market is witnessing notable growth across diverse regions, each exhibiting unique characteristics. North America dominates the market, propelled by escalating obesity rates and robust healthcare infrastructure. The region's focus on innovative drug development and supportive regulatory frameworks further bolsters its market leadership. Europe follows, driven by increasing health consciousness and government initiatives to curb obesity prevalence. The region benefits from a strong pharmaceutical industry and collaborative research efforts. In the Asia Pacific, the market is expanding rapidly, driven by rising obesity rates and increasing healthcare expenditure. Countries like China and India are emerging as significant growth pockets due to their large population base and improving healthcare access. Latin America and the Middle East & Africa are also witnessing growth, albeit at a slower pace. In these regions, rising awareness and government initiatives to combat obesity are creating new opportunities for market expansion.

Key Trends and Drivers:

The Anti-Obesity Drugs Market is experiencing robust growth fueled by rising obesity rates and increasing awareness of health risks. Technological advancements in drug development have led to more effective treatments with fewer side effects, driving market expansion. Lifestyle changes and sedentary habits are contributing to higher obesity prevalence, necessitating pharmaceutical interventions. Government initiatives and healthcare policies promoting weight management and obesity prevention are further propelling the market. The demand for personalized medicine is encouraging innovation in targeted therapies, enhancing drug efficacy and patient outcomes. Additionally, the integration of digital health tools is supporting patient adherence and monitoring, bolstering treatment success. Emerging markets present lucrative opportunities due to growing healthcare infrastructure and rising disposable incomes. Strategic partnerships and collaborations among pharmaceutical companies are fostering research and development, accelerating the introduction of novel anti-obesity drugs. As awareness of obesity-related complications increases, the market is poised for sustained growth, with a focus on holistic and patient-centric solutions.

Restraints and Challenges:

The Anti-Obesity Drugs Market is currently confronted with several significant restraints and challenges. A primary restraint is the stringent regulatory environment, which imposes rigorous approval processes, delaying the introduction of new drugs to the market. This regulatory complexity often results in increased costs and extended timelines for pharmaceutical companies. Another challenge is the high cost of drug development and commercialization, which can deter investment and innovation. Many companies face financial barriers when attempting to bring novel anti-obesity solutions to market. Additionally, there is a persistent stigma associated with obesity, leading to low patient adherence and reluctance to seek treatment, which undermines market potential. Moreover, the market is hindered by the limited efficacy and side effects of current anti-obesity medications, which often fail to meet patient and physician expectations. Lastly, the growing emphasis on lifestyle and dietary interventions as first-line treatments further diminishes the demand for pharmacological solutions, impacting market growth.

Key Players:

Orexigen Therapeutics, Vivus, Arena Pharmaceuticals, Zafgen, Rhythm Pharmaceuticals, Novo Nordisk, Gelesis, Eisai Co Ltd, Alizyme Therapeutics, NeuroSearch, Sorrento Therapeutics, Amgen, Allergan, Saniona, 8i Ventures

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Anti Obesity Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Anti Obesity Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Form
  • 2.10 Key Highlights of the Market, by End User
  • 2.11 Key Highlights of the Market, by Device
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Form
  • 3.9 Market Attractiveness Analysis, by End User
  • 3.10 Market Attractiveness Analysis, by Device
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Anti Obesity Drugs Market Outlook

  • 4.1 Anti Obesity Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Anti Obesity Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Anti Obesity Drugs Market Size

  • 6.1 Anti Obesity Drugs Market Size, by Value
  • 6.2 Anti Obesity Drugs Market Size, by Volume

7: Anti Obesity Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Prescription Drugs
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Over-the-Counter Drugs
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Herbal Supplements
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Anti Obesity Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Appetite Suppressants
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Metabolic Enhancers
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fat Absorption Inhibitors
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Combination Drugs
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Anti Obesity Drugs Market, by Services

  • 9.1 Market Overview
  • 9.2 Consultation Services
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Weight Management Programs
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Lifestyle Counseling
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Anti Obesity Drugs Market, by Technology

  • 10.1 Market Overview
  • 10.2 Pharmacogenomics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Nanotechnology
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Biotechnology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Anti Obesity Drugs Market, by Component

  • 11.1 Market Overview
  • 11.2 Active Pharmaceutical Ingredients
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Excipients
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: Anti Obesity Drugs Market, by Application

  • 12.1 Market Overview
  • 12.2 Chronic Obesity
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Weight Management
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Anti Obesity Drugs Market, by Form

  • 13.1 Market Overview
  • 13.2 Tablets
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Capsules
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Liquid
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Injectables
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Anti Obesity Drugs Market, by End User

  • 14.1 Market Overview
  • 14.2 Hospitals
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinics
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Home Care Settings
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Wellness Centers
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Anti Obesity Drugs Market, by Device

  • 15.1 Market Overview
  • 15.2 Medical Devices
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Wearable Devices
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Anti Obesity Drugs Market, by Mode

  • 16.1 Market Overview
  • 16.2 Oral
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Injectable
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: Anti Obesity Drugs Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Component
    • 17.2.7 North America Market Size and Forecast, by Application
    • 17.2.8 North America Market Size and Forecast, by Form
    • 17.2.9 North America Market Size and Forecast, by End User
    • 17.2.10 North America Market Size and Forecast, by Device
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Component
      • 17.2.9.6 United States Market Size and Forecast, by Application
      • 17.2.9.7 United States Market Size and Forecast, by Form
      • 17.2.9.8 United States Market Size and Forecast, by End User
      • 17.2.9.9 United States Market Size and Forecast, by Device
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Component
      • 17.2.10.6 Canada Market Size and Forecast, by Application
      • 17.2.10.7 Canada Market Size and Forecast, by Form
      • 17.2.10.8 Canada Market Size and Forecast, by End User
      • 17.2.10.9 Canada Market Size and Forecast, by Device
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Component
    • 17.3.7 Europe Market Size and Forecast, by Application
    • 17.3.8 Europe Market Size and Forecast, by Form
    • 17.3.9 Europe Market Size and Forecast, by End User
    • 17.3.10 Europe Market Size and Forecast, by Device
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.8 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Component
      • 17.3.10.6 Germany Market Size and Forecast, by Application
      • 17.3.10.7 Germany Market Size and Forecast, by Form
      • 17.3.10.8 Germany Market Size and Forecast, by End User
      • 17.3.10.9 Germany Market Size and Forecast, by Device
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Component
      • 17.3.11.6 France Market Size and Forecast, by Application
      • 17.3.11.7 France Market Size and Forecast, by Form
      • 17.3.11.8 France Market Size and Forecast, by End User
      • 17.3.11.9 France Market Size and Forecast, by Device
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Component
      • 17.3.12.6 Spain Market Size and Forecast, by Application
      • 17.3.12.7 Spain Market Size and Forecast, by Form
      • 17.3.12.8 Spain Market Size and Forecast, by End User
      • 17.3.12.9 Spain Market Size and Forecast, by Device
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Component
      • 17.3.13.6 Italy Market Size and Forecast, by Application
      • 17.3.13.7 Italy Market Size and Forecast, by Form
      • 17.3.13.8 Italy Market Size and Forecast, by End User
      • 17.3.13.9 Italy Market Size and Forecast, by Device
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Component
      • 17.3.14.6 Netherlands Market Size and Forecast, by Application
      • 17.3.14.7 Netherlands Market Size and Forecast, by Form
      • 17.3.14.8 Netherlands Market Size and Forecast, by End User
      • 17.3.14.9 Netherlands Market Size and Forecast, by Device
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Component
      • 17.3.15.6 Sweden Market Size and Forecast, by Application
      • 17.3.15.7 Sweden Market Size and Forecast, by Form
      • 17.3.15.8 Sweden Market Size and Forecast, by End User
      • 17.3.15.9 Sweden Market Size and Forecast, by Device
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Component
      • 17.3.16.6 Switzerland Market Size and Forecast, by Application
      • 17.3.16.7 Switzerland Market Size and Forecast, by Form
      • 17.3.16.8 Switzerland Market Size and Forecast, by End User
      • 17.3.16.9 Switzerland Market Size and Forecast, by Device
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Component
      • 17.3.17.6 Denmark Market Size and Forecast, by Application
      • 17.3.17.7 Denmark Market Size and Forecast, by Form
      • 17.3.17.8 Denmark Market Size and Forecast, by End User
      • 17.3.17.9 Denmark Market Size and Forecast, by Device
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Component
      • 17.3.18.6 Finland Market Size and Forecast, by Application
      • 17.3.18.7 Finland Market Size and Forecast, by Form
      • 17.3.18.8 Finland Market Size and Forecast, by End User
      • 17.3.18.9 Finland Market Size and Forecast, by Device
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Component
      • 17.3.19.6 Russia Market Size and Forecast, by Application
      • 17.3.19.7 Russia Market Size and Forecast, by Form
      • 17.3.19.8 Russia Market Size and Forecast, by End User
      • 17.3.19.9 Russia Market Size and Forecast, by Device
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.9 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Component
      • 17.4.9.6 China Market Size and Forecast, by Application
      • 17.4.9.7 China Market Size and Forecast, by Form
      • 17.4.9.8 China Market Size and Forecast, by End User
      • 17.4.9.9 China Market Size and Forecast, by Device
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Component
      • 17.4.10.6 India Market Size and Forecast, by Application
      • 17.4.10.7 India Market Size and Forecast, by Form
      • 17.4.10.8 India Market Size and Forecast, by End User
      • 17.4.10.9 India Market Size and Forecast, by Device
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Component
      • 17.4.11.6 Japan Market Size and Forecast, by Application
      • 17.4.11.7 Japan Market Size and Forecast, by Form
      • 17.4.11.8 Japan Market Size and Forecast, by End User
      • 17.4.11.9 Japan Market Size and Forecast, by Device
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Component
      • 17.4.12.6 South Korea Market Size and Forecast, by Application
      • 17.4.12.7 South Korea Market Size and Forecast, by Form
      • 17.4.12.8 South Korea Market Size and Forecast, by End User
      • 17.4.12.9 South Korea Market Size and Forecast, by Device
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Component
      • 17.4.13.6 Australia Market Size and Forecast, by Application
      • 17.4.13.7 Australia Market Size and Forecast, by Form
      • 17.4.13.8 Australia Market Size and Forecast, by End User
      • 17.4.13.9 Australia Market Size and Forecast, by Device
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Component
      • 17.4.14.6 Singapore Market Size and Forecast, by Application
      • 17.4.14.7 Singapore Market Size and Forecast, by Form
      • 17.4.14.8 Singapore Market Size and Forecast, by End User
      • 17.4.14.9 Singapore Market Size and Forecast, by Device
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Component
      • 17.4.15.6 Indonesia Market Size and Forecast, by Application
      • 17.4.15.7 Indonesia Market Size and Forecast, by Form
      • 17.4.15.8 Indonesia Market Size and Forecast, by End User
      • 17.4.15.9 Indonesia Market Size and Forecast, by Device
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Component
      • 17.4.16.6 Taiwan Market Size and Forecast, by Application
      • 17.4.16.7 Taiwan Market Size and Forecast, by Form
      • 17.4.16.8 Taiwan Market Size and Forecast, by End User
      • 17.4.16.9 Taiwan Market Size and Forecast, by Device
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Component
      • 17.4.17.6 Malaysia Market Size and Forecast, by Application
      • 17.4.17.7 Malaysia Market Size and Forecast, by Form
      • 17.4.17.8 Malaysia Market Size and Forecast, by End User
      • 17.4.17.9 Malaysia Market Size and Forecast, by Device
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Component
    • 17.5.7 Latin America Market Size and Forecast, by Application
    • 17.5.8 Latin America Market Size and Forecast, by Form
    • 17.5.9 Latin America Market Size and Forecast, by End User
    • 17.5.10 Latin America Market Size and Forecast, by Device
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Component
      • 17.5.9.6 Brazil Market Size and Forecast, by Application
      • 17.5.9.7 Brazil Market Size and Forecast, by Form
      • 17.5.9.8 Brazil Market Size and Forecast, by End User
      • 17.5.9.9 Brazil Market Size and Forecast, by Device
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Component
      • 17.5.10.6 Mexico Market Size and Forecast, by Application
      • 17.5.10.7 Mexico Market Size and Forecast, by Form
      • 17.5.10.8 Mexico Market Size and Forecast, by End User
      • 17.5.10.9 Mexico Market Size and Forecast, by Device
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Component
      • 17.5.11.6 Argentina Market Size and Forecast, by Application
      • 17.5.11.7 Argentina Market Size and Forecast, by Form
      • 17.5.11.8 Argentina Market Size and Forecast, by End User
      • 17.5.11.9 Argentina Market Size and Forecast, by Device
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.9 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Component
      • 17.6.10.6 UAE Market Size and Forecast, by Application
      • 17.6.10.7 UAE Market Size and Forecast, by Form
      • 17.6.10.8 UAE Market Size and Forecast, by End User
      • 17.6.10.9 UAE Market Size and Forecast, by Device
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Component
      • 17.6.11.6 South Africa Market Size and Forecast, by Application
      • 17.6.11.7 South Africa Market Size and Forecast, by Form
      • 17.6.11.8 South Africa Market Size and Forecast, by End User
      • 17.6.11.9 South Africa Market Size and Forecast, by Device
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Orexigen Therapeutics
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Vivus
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Arena Pharmaceuticals
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Zafgen
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Rhythm Pharmaceuticals
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Novo Nordisk
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Gelesis
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Eisai Co Ltd
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Alizyme Therapeutics
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 NeuroSearch
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Sorrento Therapeutics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Amgen
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Allergan
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Saniona
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 8i Ventures
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제